The proposed model of pathological changes in the neurons of patients with JNCL (Batten disease) also suggests the possibility of using inhibitors of EGFR [24] and ERK1/2, JNKs and p38 signaling [25]. Here, MAPK3 is linked to juvenile neuronal ceroid lipofuscinosis.